Toyama et al used a score based on hematologic and cytogenetic findings to predict the prognosis for patients with the myelodysplasia syndrome. This can help identify those patients who may require more aggressive management and monitoring. The authors are from the Tokyo Medical College and the Japanese Study Group for Intractable Hematopoietic Disease.

To read more or access our algorithms and calculators, please log in or register.